Navigation Links
Mesa Science Associates’ Co-Author a Paper on Cyanide Poisoning Presented at the 13th Annual NIH Counter Act Meeting
Date:6/29/2019

Mr. Michael Mesa, President and CEO at Mesa Science Associates Inc. (MSA) announced today that MSA was a sponsor and participant at the 13th annual NIH Counter ACT meeting held on June 18-20 at the New York Academy of Sciences. The purpose of the meeting was to discuss the latest research aimed treating threats from chemical and biological agents. The biological threat agents include anthrax, smallpox as well as emerging newer toxins. The chemical threats include vesicants such as mustard and chlorine gases, nerve agents including sarin and VX, and respiratory depressants such as cyanide.

For the last several years MSA has collaborated on a cyanide project with researchers from the University of California and provided a co-investigator for an NIH grant awarded to Dr. Gerry Boss at the University of California, San Diego. The Grant (U01 NS105057), has allowed Dr. Boss to direct his research towards developing new antidotes to cyanide poisoning. In addition to it’s potential as a chemical threat agent, cyanide is also produced in residential and commercial fires and is a lethal component associated with smoke inhalation. MSA Associates, Ken Dretchen PhD, Matt Robben PhD and Michael Mesa were co-authors on a paper demonstrating the results from the past years research. MSA co-authors were listed on the paper and an associated poster by co-authors from the University of Colorado, The University of California Irvine, the University of Colorado and SRI international. The paper, presented by Dr Boss, was entitled “Sodium Tetrathionate as a Cyanide Antidote”. The scientific report demonstrated that the proposed drug is capable of immediately reversing respiratory depression associated with cyanide intoxication in several different animal species and at a dose which should be safe and effective in humans. The results of this study will be the basis of future discussions with the Food and Drug Administration regarding advancing this drug product to the next stage of development.

In addition, Dr. Matt Robben from MSA presented a paper at the meeting entitled “Drug Product Formulations: Planning Efficient Formulation Transition from Discovery to First Human Trials”. The paper was extremely well received as it provided valuable advice to the attendees on how to overcome drug formulation issues associated with transitioning a potential medical countermeasure product from the discovery stage to pre-clinical trials and ultimately to human clinical trials.

Mesa Science Associates Inc is located inside the Frederick Innovation and Technology Center at 4539 Metropolitan Ct. in Frederick Md.

Read the full story at https://www.prweb.com/releases/mesa_science_associates_co_author_a_paper_on_cyanide_poisoning_presented_at_the_13th_annual_nih_counter_act_meeting/prweb16411220.htm.


'/>"/>
Source: PRWeb
Copyright©2019 Vocus, Inc.
All rights reserved


Related medicine news :

1. Promoting chemistry through cooking: American Chemical Society Prized Science video
2. OU natural products discovery group asks for publics help with citizen science program
3. AACR to host Annual Conference on Science of Cancer Health Disparities
4. BTV-Business Television Rising Stars in Life Sciences with Verisante, Vivione, biOasis, Theralase and Aurora Spine
5. Polish Academy Of Sciences awards LSUHSCs Bazan Medal
6. Kidney Week 2013: New innovations in clinical science
7. Global Life Sciences Consulting Firm, MAETRICS, Appoints Fortune 100 Sales Executive, R.J. Lemieux.
8. Western University of Health Sciences’ Gala Fundraiser Emphasizes Humanism and Caring
9. Feinstein Institute Encourages Science Education for NY Area Middle and High School Students
10. Nutrition Science Initiative Recruits Exceptional Leader in Behavior and Metabolism
11. GeoScience.net Publishes 40,188 New Abstracts on Biological Alteration
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/1/2020)... ... September 01, 2020 , ... ... fellowship training in aesthetic surgery of the face, breast, and body. In 2018, ... female-owned premier boutique plastic surgery and aesthetic practice in Southwest Florida. Dr. Gill ...
(Date:8/31/2020)... ... August 31, 2020 , ... The Lymphoma Research Foundation ... lymphoma research and serving the lymphoma community through a comprehensive series of education ... Blood Cancer Awareness Month (BCAM) and its international Light it Red for ...
(Date:8/31/2020)... ... August 31, 2020 , ... ... 1,400 N95 face masks to medical first responders across the United States. Since ... donations of personal protective equipment (PPE) medical centers , hospitals , ...
(Date:8/31/2020)... ... August 31, 2020 , ... ... solution for chiropractors, announced today the launch of its integrated, HIPAA compliant, telehealth ... running their virtual practice in under 90 seconds. , According to the ...
(Date:8/31/2020)... , ... August 31, 2020 , ... ... support services to dental groups in the United States, today announced the grand ... of Beaumont, CA. , Patients will enjoy convenient hours, a comfortable office, ...
Breaking Medicine News(10 mins):
(Date:8/27/2020)... HILL, N.C. (PRWEB) , ... August 27, 2020 , ... ... professional football player and sleep apnea patient, is the company’s new spokesperson. , “In ... the football field. So, when I found the Bleep DreamPort it was a Bleeping ...
(Date:8/26/2020)... ... August 26, 2020 , ... ScripHessco has announced ... The infographic breaks down ways that chiropractors can help heal sports injuries and ... ScripHessco “Athletes have an unusual amount of pressure and stress on their bodies, ...
(Date:8/26/2020)... ... August 26, 2020 , ... Clinical ... definitive agreement to acquire ProCE, a nationally recognized provider of continuing education ... , CEA represents a growing alliance of CME/CE and service organizations that ...
Breaking Medicine Technology: